DURATIO
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0004407
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 4748
1) patients with acute ischemic stroke or transient ischemic attack with positive DWI lesions within 7 days of onset,
2) patients starting treatment with clopidogrel-aspirin within 7 days of onset,
3) patients with presumed large artery atherosclerotic origin according to the TOAST classification,
4) patients signed informed consent
1) Ineligible and unwilling to maintain over 3-months DAPT based on the physician’s discretion,
2) Eligible and willing to maintain over 3-months DAPT based on the physician’s discretion
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a composite of stroke, myocardial infarction, or all-causea mortality
- Secondary Outcome Measures
Name Time Method 1-year all types of stroke (either ischemic or hemorrhagic stroke);1-year ischemic stroke;1-year hemorrhagic stroke;1-year all-cause mortality;1-year major bleeding